Olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders

被引：6
|
作者：
Tran, PV [1 ]
Tollefson, GD [1 ]
Andersen, SW [1 ]
Kuntz, AJ [1 ]
Hamilton, SH [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
SCHIZOPHRENIA RESEARCH | 1998年 / 29卷 / 1-2期
关键词：
D O I：
10.1016/S0920-9964(97)88828-7
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
下载
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [31] RISPERIDONE AND OLANZAPINE IN TREATMENT OF DELUSIONAL DISORDERS
    Zivkovic, N.
    Bajovic, B.
    Djokic, G.
    Pavicevic, D.
    Nenadovic, M.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [32] Superiority of olanzapine over risperidone in the control of negative symptoms of schizophrenia and related psychotic disorders in older patients
    Sutton, VK
    Street, JS
    Kennedy, JS
    Feldman, PD
    Breier, A
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 62S - 62S
  • [33] Superiority of olanzapine over risperidone in the control of negative symptoms of schizophrenia and related psychotic disorders in older patients
    Sutton, VK
    Street, JS
    Kennedy, JS
    Feldman, PD
    Breier, A
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1082 - 1082
  • [34] Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders
    Dold, Markus
    Samara, Myrto T.
    Li, Chunbo
    Tardy, Magdolna
    Leucht, Stefan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01):
  • [35] Risperidone and olanzapine in treatment of delusional disorders
    Zivkovic, N.
    Djokic, G.
    Pavicevic, D.
    Bajovic, B.
    Ilic, M.
    Tomic, M.
    Lekovic, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S474 - S474
  • [36] TREATMENT OF PSYCHOTIC EPISODE IN EPILEPSY - OLANZAPINE VS RISPERIDONE
    Ravanic, D.
    Dejanovic, S. Djukic
    Ignjatovic, D. Ristic
    Ilic, M.
    Borovcanin, M.
    Babic, S.
    Jovanovic, M.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [37] Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation
    Villari, Vincenzo
    Rocca, Paola
    Fonzo, Valeria
    Montemagni, Cristiana
    Pandullo, Pasquale
    Bogetto, Filippo
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (02): : 405 - 413
  • [38] Longitudinal course and outcome: Schizophrenia versus other psychotic disorders
    Harrow, M
    Sands, JR
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 17 - 17
  • [39] Medical resource use and work and social outcomes for olanzapine compared with haloperidol in the treatment of schizophrenia and other psychotic disorders
    Hamilton, SH
    Genduso, LA
    Revicki, DA
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 148 - 149
  • [40] Quality of life outcomes for olanzapine and haloperidol treatment for schizophrenia and other psychotic disorders: Results of an international clinical trial
    Revicki, D
    Haley, J
    Hamilton, S
    Genduso, L
    Beasley, C
    QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 315 - 315
12345